Agoraphobia
Fear of places and situations that might cause panic, helplessness, or embarrassment.
Agoraphobia is an anxiety disorder that often develops after one or more panic attacks.
Symptoms include fear and avoidance of places and situations that might cause feelings of panic, entrapment, helplessness, or embarrassment.
Treatments include talk therapy and medication.
Cluster Number: F-1
Wiki Number: W003
Diagnosis: Agoraphobia
US Patients: 1.7% Adults
World Patients:
Sex Ratio: M-2W
Age Onset: 20+
Brain Area: Extra epinephrine – poor balance
Symptoms: environment unsafe-no escape
Progression: Open spaces or outside home; may lead to 10-30 minute panic attack or PTSD
Causes:
Medications: antidepressants; anti-anxiety
Therapies: relaxation, systematic desensitization, expanding exposuresCBT-50%
DRUG DISCOUNT PROGRAMS WHICH MAY BE AVAILABLE.
(This may not be a complete lists of companies offering drug discounts.)
1. GoodRx.com-On their website type in the name of the drug for coupons and get prices from pharmacy chain-stores. Discounts can range up to 80% and their card will be honored in 70,000 pharmacies.
2. Optum Perks Discount Card-Their website allows registration for their cards for those age 13 and older. “Tools and information may very based on your plan benefits.”
3. RxSaver-com. Their website claims up to 80% savings and accepted at thousands of pharmacies with five pharmacy chains shown. Their program prints coupons on demand.
4. WellRx-Print their card from their website and then save up to 80% at pharmacy counters on 1167 drug choices. Their ad shows 20 pharmacy store-chains.
YOUTUBE VIDEOS BY DIAGNOSIS:
(Additional videos may also appear in YouTube.)
AMAZON’S BOOK TITLES BY DIAGNOSIS:
(Additional titles may also appear in Amazon.)
(Your Library may have this book, or find it through InterLibrary-Loan.)
The Agoraphobia Workbook
THIS DIAGNOSIS MAY QUALIFY FOR SCHOOL SPECIAL PROGRAM.
THIS DIAGNOSIS MAY QUALIFY FOR SOCIAL SECURITY DISABILITY BENEFITS.
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Internet psychotherapeutic interventions for anxiety disorders - a critical evaluationby Borwin Bandelow on June 29, 2022
CONCLUSIONS: IPIs may be a useful tool when face-to-face psychotherapy is not easily available, or as an add-on to standard psychotherapeutic or psychopharmacological treatments but should perhaps not be used as monotherapy. We have suggested standards for future research and the practical use of IPIs.
- French adaptation and validation of the Panic Disorder Severity Scale-self-reportby Pasquale Roberge on June 27, 2022
CONCLUSIONS: The French version of the PDSS-SR has psychometric properties consistent with the original version and constitutes a valid brief scale to assess the severity of panic disorder and change in severity over time, both in research and clinical practice.
- Not always that EASI: Validating the Russian version of the epilepsy anxiety survey instrument and its brief counterpartby Mikhail Zinchuk on June 26, 2022
CONCLUSION: The brEASI performed better than the GAD-7 in our sample and, therefore, may be considered a first-line screening tool for anxiety disorders in PWE.
- Correlations of plasma oxytocin with clinical and hormonal parameters in panic disorderby Vasilios G Masdrakis on June 17, 2022
CONCLUSION: In acutely-ill, medication-free PD patients, OXT plasma levels may be relevant to the severity of their 'general' anxiety symptoms, but not to the 'specific' panic psychopathology.